1. Home
  2. Labeler Index
  3. Adare Pharmaceuticals, Inc.
  4. 59917-091
  5. NDC Package Code: 59917-091-00 Cyclobenzaprine Hydrochloride

NDC Package 59917-091-00 Cyclobenzaprine Hydrochloride

Capsule, Extended Release - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
59917-091-00
Package Description:
1 BAG in 1 DRUM / 185000 CAPSULE, EXTENDED RELEASE in 1 BAG
Product Code:
59917-091
Non-Proprietary Name:
Cyclobenzaprine Hydrochloride
Substance Name:
Cyclobenzaprine Hydrochloride
11-Digit NDC Billing Format:
59917009100
Product Type:
Drug For Further Processing
Labeler Name:
Adare Pharmaceuticals, Inc.
Dosage Form:
Capsule, Extended Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.
Active Ingredient(s):
CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
05-12-2009
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 59917-091-00?

The NDC Packaged Code 59917-091-00 is assigned to an UNFINISHED drug package of 1 bag in 1 drum / 185000 capsule, extended release in 1 bag of Cyclobenzaprine Hydrochloride, drug for further processing labeled by Adare Pharmaceuticals, Inc.. The product's dosage form is capsule, extended release and is administered via form.

Is NDC 59917-091 included in the NDC Directory?

Yes, Cyclobenzaprine Hydrochloride is an UNFINISHED PRODUCT with code 59917-091 that is active and included in the NDC Directory. The product was first marketed by Adare Pharmaceuticals, Inc. on May 12, 2009 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 59917-091-00?

The 11-digit format is 59917009100. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-259917-091-005-4-259917-0091-00